A genicular nerve block is a minimally invasive interventional procedure that targets the genicular nerves — the articular branches derived from the femoral, tibial, common peroneal, saphenous, and obturator nerves that provide sensory innervation to the anterior, medial, and lateral compartments of the knee joint capsule. Unlike intra-articular injections that deliver medication into the joint space itself, a genicular nerve block deposits local anesthetic and corticosteroid precisely at the extra-articular locations where these sensory nerves approach the joint capsule, thereby interrupting the transmission of nociceptive signals from the osteoarthritic or degenerated knee joint before they reach the central nervous system.
The primary indication for genicular nerve block is chronic knee pain secondary to osteoarthritis (OA) in patients who have not achieved adequate relief from conservative measures — including physical therapy, activity modification, weight optimization, oral analgesics, and intra-articular corticosteroid or viscosupplementation injections — and who are either not yet candidates for total knee arthroplasty (TKA) or wish to delay surgery. For patients with advanced OA who are poor surgical candidates due to medical comorbidities or advanced age, genicular nerve block offers a safe, effective, and repeatable alternative that can meaningfully improve pain, function, and quality of life without the risks and recovery time associated with joint replacement surgery.
Equally important, genicular nerve block serves a critical diagnostic function: it is the essential prognostic tool for determining which patients are likely to derive substantial benefit from genicular nerve radiofrequency ablation (RFA). A positive response to a genicular nerve block — defined as at least 50% pain reduction lasting for the duration of the local anesthetic effect — identifies the genicular nerves as the primary pain generators and reliably predicts a favorable outcome from neuroablative therapy. At Interventional Pain Consultants, genicular nerve blocks are performed under fluoroscopic guidance by board-certified, fellowship-trained interventional pain specialists who have extensive experience in knee pain management.
The patient is positioned supine on the procedure table with the knee in neutral extension and a pillow placed under the popliteal fossa for comfort. Using fluoroscopic guidance, the three primary target locations are identified based on well-established anatomic landmarks: the superomedial genicular nerve at the junction of the femoral shaft and medial femoral condyle, the superolateral genicular nerve at the junction of the femoral shaft and lateral femoral condyle, and the inferomedial genicular nerve at the junction of the tibial shaft and medial tibial plateau.
After sterile skin preparation, a 25-gauge, 2-inch needle is advanced under fluoroscopic guidance to each of the three target sites. The needle tip is positioned precisely at the periosteal surface of the bone at the designated landmark. After negative aspiration to confirm no intravascular needle placement, a 1.0-1.5 mL mixture of local anesthetic (typically 0.5% bupivacaine) and corticosteroid (20 mg of methylprednisolone acetate per site) is deposited at each target. The injectate spreads along the periosteum adjacent to the articular branch, providing dense blockade of the target nerve. Accurate needle placement is critical — a needle positioned too far from the periosteum may miss the nerve, while placement into the joint capsule or into the popliteal fossa may produce incomplete or ineffective blockade.
The procedure is performed on an outpatient basis and requires approximately 15-20 minutes. Patients are awake throughout and require no sedation. Most patients report only mild discomfort during the procedure, primarily from the local anesthetic skin infiltration and the sensation of pressure as the needle contacts the periosteum. The injection of medication itself is typically painless.
Following the procedure, patients are monitored for 15-20 minutes. The local anesthetic effect is apparent within minutes, and patients can immediately begin to assess the degree of pain relief. For the diagnostic block, patients are asked to perform their typical pain-provoking activities — including walking, stair climbing, and rising from a seated position — over the ensuing 4-8 hours to gauge the extent of pain relief. A detailed pain diary is provided to document the duration and quality of the response.
The local anesthetic effect from the diagnostic block lasts approximately 4-12 hours, during which patients experience significant pain reduction and improved knee function. Patients are encouraged to remain active during this window to evaluate the functional impact of pain relief. As the local anesthetic wears off, pain gradually returns to baseline. Patients should not drive or operate heavy machinery for 24 hours following the procedure due to the lingering effects of the local anesthetic on knee proprioception.
If corticosteroid was included in the injectate for therapeutic purposes, the anti-inflammatory effect begins within 3-7 days and may provide several weeks of additional relief. The response to the diagnostic block — both the degree and the duration of pain relief — is documented and used to determine candidacy for genicular nerve RFA.
Genicular nerve blocks are most effective in patients whose chronic knee pain has a predominantly nociceptive component arising from the joint itself — characterized by deep, aching pain that worsens with weight-bearing activity, improves with rest, and is localized to the anterior and medial knee. The presence of significant mechanical instability, fixed flexion deformity, or severe malalignment may limit the degree of benefit achievable from this approach. Patients with primarily patellofemoral symptoms may also respond well, though the innervation of the patellofemoral joint involves additional nerve branches that may not be covered by the standard three-site block.
Contraindications include active infection at the injection sites, coagulopathy or anticoagulant therapy that cannot be safely interrupted, known allergy to local anesthetics or corticosteroids, and preexisting neuromuscular deficits affecting the lower extremity that could be masked by the block. At Interventional Pain Consultants, we take a comprehensive approach to knee pain management, integrating genicular nerve procedures with physical therapy, bracing, activity modification, and weight management to achieve the best possible long-term outcomes for every patient.
Reducing Pain. Improving Function. Enhancing Quality of Life.
We specialize in advanced pain management solutions, offering minimally invasive treatments to help patients live pain-free and improve their quality of life.